Security · CUSIP 62921N105
NGM BIOPHARMACEUTICALS INC
COM · institutional ownership from 13F filings
13F holders
0
Shares held
0
Value held
$0
New / sold out
0 / 75
Added / reduced
0 / 0
net -35.0M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2024
Nothing to show.
Biggest buyers
Nothing to show.
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Column Group LLC | Sold out | -18,136,735 | -100.0% |
| BlackRock Inc. | Sold out | -3,004,210 | -100.0% |
| VANGUARD GROUP INC | Sold out | -2,324,392 | -100.0% |
| StepStone Group LP | Sold out | -1,573,357 | -100.0% |
| Euclidean Capital LLC | Sold out | -992,168 | -100.0% |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -983,836 | -100.0% |
| Trium Capital LLP | Sold out | -977,965 | -100.0% |
| STATE STREET CORP | Sold out | -823,111 | -100.0% |
| ADAR1 Capital Management, LLC | Sold out | -816,581 | -100.0% |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -611,300 | -100.0% |
65 more rows. Subscribe for $29/month to see every row, download the data and use the API.